Newsletter | June 25, 2019

06.25.19 -- Seven Strategies To Avoid Delays In Clinical Supply

Seven Strategies To Avoid Delays In Clinical Supply

Ensuring an adequate, timely, and quality supply of comparator product for clinical trials is critical, but clinical trial sponsors face several challenges in this endeavor. Delivery delays or under-projection of needed quantities could have a negative impact on timelines, budgets, and patients relying on new treatment options for unmet needs. In this article, learn seven strategies to help you avoid clinical supply delays.

Managing Risks To Time-Critical Product Imports At Clinical Supply Depots

Global regulatory standards for clinical trials are, simply put, complex. In this case study, learn how one company worked with its partner to overcome the challenge of a protocol based in the U.S., an investigational medical product (IMP) approved in the EU, and varying QP (qualified person) rules from country to country, to conduct their clinical trial in Israel.

Clinical Supply Chain Transformation Through Innovation

Even with forecasting and building out a sizeable buffer inventory, clinical sites may still not always have the appropriate kits on hand to dispense to patients. Why?

Questions You Need To Ask About Clinical Supply

Planning on using a CRO to support your next clinical study? Here are the top nine questions you should always ask to help your CRO or partner of choice better understand your clinical supply needs.